Interestingly, plasma samples from AD patients have shown that levels of pro-ADM and pro-ANP were increased compared to healthy subjects, in contrast to the levels of C-terminal ET-1 precursor fragment (CT-proET-1) which were decreased [83]. This evidence concerns the gene NPPA and Alzheimer disease.